Plus therapeutics reports third quarter 2022 financial results and business highlights

Awarded $17.6 million product development research grant by the cancer prevention & research institute of texas (cprit) to fund 186 rnl development for leptomeningeal metastases (lm)
pstv Ratings Summary
pstv Quant Ranking